Study exposes opportunities for strengthening cancer drugs trials in China
More than one-eighth of the randomized trials of cancer drugs seeking regulatory approval in China in recent years used inappropriate controls to test the effectiveness and safety of the drugs, according to a new study published ...
Dec 12, 2023
0
0